长期免疫静息后HIV-1中和抗体应答的快速增强
研究纳入16名5-17年前曾接受HIV-1 B亚型Env疫苗(MF59佐剂)初免的健康志愿者和20名未初免者,给予异源C亚型三聚体gp140蛋白疫苗加强。长期免疫静息后单剂蛋白加强使100%初免者结合与中和抗体滴度升高,75%初免者CD4+ T细胞应答增强,但未发现跨亚型中和抗体应答显著拓宽的证据。
要点
- 长期免疫静息后单剂蛋白加强可快速增强初免者结合与中和抗体应答。
- 初免者中CD4+ T细胞应答在单剂加强后于75%个体中增强。
- 未发现跨亚型加强显著拓宽中和抗体应答的证据。
核心结论
- HIV-1蛋白免疫原可诱导持久的记忆T细胞和B细胞应答。
- 长期免疫静息后单剂蛋白加强可诱导强效的1级病毒中和应答。
- 未发现跨亚型加强显著拓宽中和抗体应答的证据。
研究设计与样本
- 研究纳入16名5-17年前接受HIV-1 B亚型Env疫苗(MF59佐剂)初免的健康志愿者和20名未初免健康志愿者。
- 初免组接受三剂异源C亚型三聚体gp140蛋白疫苗加强,未初免组接受相同C亚型gp140蛋白疫苗方案。
主要发现
- 多数既往初免者中可检测到针对1级病毒分离株的结合抗体和中和抗体。
- 长期免疫静息后单剂蛋白加强使100%初免者结合和中和抗体滴度升高。
- 单剂加强后75%初免个体CD4+ T细胞应答增强。
临床怎么用
- 提示HIV-1疫苗设计可利用长期免疫记忆,单剂蛋白加强即可快速增强抗体应答。
- 跨亚型加强策略对拓宽中和抗体应答的作用有限,需进一步优化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The durability and breadth of human immunodeficiency virus type 1 (HIV-1)-specific immune responses elicited through vaccination are important considerations in the development of an effective HIV-1 vaccine. Responses to HIV-1 envelope subunit protein (Env) immunization in humans are often described as short-lived. METHODS: We enrolled 16 healthy volunteers who had received priming with an HIV-1 subtype B Env vaccine given with MF59 adjuvant 5-17 years previously and 20 healthy unprimed volunteers. Three booster immunizations with a heterologous subtype C trimeric gp140 protein vaccine were administered to the primed group, and the same subtype C gp140 protein vaccination regimen was administered to the unprimed subjects. RESULTS: Binding antibodies and neutralizing antibodies to tier 1 viral isolates were detected in the majority of previously primed subjects. Remarkably, a single dose of protein boosted binding and neutralizing antibody titers in 100% of primed subjects following this prolonged immunologic rest period, and CD4+ T-cell responses were boosted in 75% of primed individuals. CONCLUSIONS: These results demonstrate that HIV-1 protein immunogens can elicit durable memory T- and B-cell responses and that strong tier 1 virus neutralizing responses can be elicited by a single booster dose of protein following a long immunologic rest period. However, we found no evidence that cross-clade boosting led to a significantly broadened neutralizing antibody response.
引用
- Spearman P, Tomaras GD, Montefiori DC, et al. Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period. J Infect Dis. 2019. PMID: 30615119. doi:10.1093/infdis/jiz008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。